Non-Surgical Joint Care Solutions in Fresno, CA

The numbers that actually change how you stock in Fresno

CDC PLACES (2023, crude) estimates 12.7% of adults in Fresno have diagnosed diabetes — 0.7 points above the U.S. 12% figure. Obesity 37.5%; arthritis 21.2%. Those three PLACES crude rates (plus Census 542,107) are the local facts on this page. Everything else is the national non surgical joint care catalog and JE paperwork.

If you already “have a vendor”

• Adult arthritis here is 21.2% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. 15.3% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. PRP is autologous and not a 361 allograft, but “patient prefers regenerative” is still not medical necessity in California.
• PRP is autologous and not an HCT/P 361 allograft, but payers in JE still expect diagnosis-driven documentation. A 1-minute spin does not replace a medically necessary indication or a procedure note.
• California is outside CDC's historical Diabetes Belt core, but the national 12% diabetes figure still applies as a planning baseline until a clinic uses its own payer mix. Clinics asking for regenerative inventory still have to separate HCT/P 361 homologous-use products from unapproved “stem cell” claims (FDA 21 CFR 1271).

Why we will not invent a Fresno diabetes rate

15.3% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. A city of 500k–1M with 542,107 residents will still mix those payers. CDC PLACES (2023, crude) estimates 12.7% of adults in Fresno have diagnosed diabetes — 0.7 points above the U.S. 12% figure. Build two utilization policies if you do both cash PRP and Medicare CTPs.

Do this before you expand SKUs